Novartis AG vs Rigetti Computing Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Rigetti Computing Inc trades at $15.44 (market cap $4.74B). The key difference: Novartis AG is far larger — about 61.2× Rigetti Computing Inc's market cap, and Novartis AG pays a 3.17% dividend while Rigetti Computing Inc pays none. Which is the better fit depends on your goals.
| NVS | RGTI | |
|---|---|---|
Market Cap | $290.25B | $4.74B |
Sector | Health | Technology |
52-Week High | $168.62 | $56.34 |
52-Week Low | $113.50 | $12.90 |
Enterprise Value | $330.27B | $4.33B |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Rigetti Computing, Inc. is a pioneer in quantum computing, focusing on developing and deploying quantum-classical computing systems. The company designs and fabricates superconducting quantum processors and integrates them with a full-stack software and control platform. Rigetti offers access to its quantum computers through the cloud, aiming to solve complex computational problems that are intractable for classical computers, with applications in finance, chemistry, and machine learning.
Read more on RGTI →